Compare Arimidex vs. Xeloda

Head-to-head comparisons of medication uses, side effects, ratings, and more.

ADVERTISEMENT
No information currently available
No information currently available
Upsides
No information currently available
No information currently available
Downsides
No information currently available
No information currently available
ADVERTISEMENT
Used for
  • Breast cancer
  • Adjuvant
  • Postmenopausal
  • Hormone receptor-positive. Breast cancer
  • Advanced
  • Postmenopausal
  • Following tamoxifen therapy. Breast cancer
  • Locally advanced or metastatic
  • Postmenopausal
  • Hormone receptor-positive or unknown
  • First-line
  • Breast cancer
  • Neoadjuvant treatment for hormone receptor-positive
  • Operable or potentially operable
  • Locally advanced disease in postmenopausal women. Breast cancer
  • Postmenopausal women at high risk; Prophylaxis
  • Colon cancer
  • Adjuvant therapy
  • Duke's Stage C
  • When treatment with a fluoropyrimidine alone is preferred. Metastatic breast cancer
  • In combination with docetaxel after failure of prior anthracycline-containing regimens. Metastatic breast cancer
  • Monotherapy
  • When resistant to paclitaxel/anthracycline-containing regimens or resistant to paclitaxel and not a candidate for further anthracycline therapy. Metastatic colorectal cancer
  • First-line therapy when treatment with a fluoropyrimidine alone is preferred.
  • Colon cancer
  • Adjuvant therapy
  • Stage III
  • In combination with oxaliplatin. Colorectal cancer
  • Unresectable
  • Advanced
  • Or metastatic; first-line in combination with oxaliplatin. Esophagogastric cancer
  • Advanced or metastatic
  • In combination with chemotherapeutic agents. Esophagogastric cancer
  • First-line therapy for advanced or metastatic disease
  • In combination with epirubicin and oxaliplatin or cisplatin. Gastric cancer
  • First-line therapy for advanced or metastatic disease
  • In combination with chemotherapeutic agents. Gastric cancer
  • First-line therapy for advanced or metastatic disease
  • In combination with epirubicin and oxaliplatin or cisplatin. Gastric cancer
  • Stage II to IIIB
  • Adjuvant therapy in combination with oxaliplatin. Malignant tumor of rectum
  • Locally advanced
  • Adjuvant or neoadjuvant therapy
  • In combination with radiotherapy. Metastatic breast cancer
  • HER2 overexpression
  • In combination with trastuzumab. Metastatic breast cancer
  • In combination with bevacizumab in patients previously treated with an anthracycline and a taxane. Metastatic colorectal cancer
  • Combination therapy with irinotecan. Metastatic colorectal cancer
  • First-line therapy
  • In combination with bevacizumab and oxaliplatin. Metastatic renal cell carcinoma. Ovarian cancer. Pancreatic cancer
  • Monotherapy.
Dosage forms
  • Pill
  • Pill
Price
Want to save even more money?
Sign up now for a 30-day trial and save up to 95% at CVS, Kroger, Albertsons, and other pharmacies.
Learn more
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
The Arimidex (Anastrozole) FDA package insert doesn’t have numbers about how common side effects are.
The Xeloda (Capecitabine) FDA package insert doesn’t have numbers about how common side effects are.
Risks and risk factors
No information currently available
No information currently available